To further examine this potential relationship between platelet activation and thrombotic events, we compared CD63 induction by plasma from COVID-19 patients with future thrombotic events, patients with past thrombotic events, patients who never experience thrombotic complications and COVID-19 recovered patients (Figure 2D). The gene discussed is CD63; the disease is COVID-19.